Cargando…
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
Autores principales: | Friedli, Christoph, Diem, Lara, Hammer, Helly, Kamber, Nicole, Suter-Riniker, Franziska, Leib, Stephen, Chan, Andrew, Hirzel, Cédric, Hoepner, Robert, Salmen, Anke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135211/ https://www.ncbi.nlm.nih.gov/pubmed/34046087 http://dx.doi.org/10.1177/17562864211016641 |
Ejemplares similares
-
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
por: Hammer, Helly, et al.
Publicado: (2022) -
Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
por: Pistor, Maximilian, et al.
Publicado: (2022) -
Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study
por: Diem, Lara, et al.
Publicado: (2022) -
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology,
Comorbidities and Association With Initial Course of COVID-19
por: Diem, Lara, et al.
Publicado: (2022) -
Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
por: Diem, Lara, et al.
Publicado: (2021)